Navigation Links
Stolen gene allows insect virus to enter cells

A gene enabling an insect virus to enter new cells was likely stolen from a host cell and adapted for the virus's use, researchers at Boyce Thompson Institute (BTI) at Cornell University report.

Virologists have long thought of baculoviruses, a group of viruses that can liquefy their insect hosts in a matter of days but don't induce so much as a sneeze in mammals, as potential pesticides. But the viruses would require tweaking to be effective since they kill insects more slowly than chemical insecticides. Studying baculoviruses also yields insights into general viral behavior. The current study examined how baculoviruses took the evolutionary leap needed to become the nasty bugs they are today.

In the study, reported in the July 1 issue of the Journal of Virology, BTI researchers Gary Blissard and Oliver Lung investigated whether a fruit fly gene, called an f gene, had originally moved from an insect to a virus or the other way around. (Retroviruses, such as HIV, insert their own genes into their hosts' DNA in order to replicate, and remnants of these invaders can be passed to descendants.) In viruses, an f gene codes for a fusion (F) protein, which enables the virus to penetrate the host cell's membrane and infect it. Scientists had shown that some other viral genes were probably copied from host cells, but the origin of so-called fusion proteins, like F, has remained a mystery.

"The gigantic step was when the Drosophila melanogaster [fruit fly] genome was published," Blissard says. "The first thing was to ask whether the gene was turned on or not, to validate whether it's a bona fide gene."

Blissard and Lung found messenger RNA (mRNA) copies of the gene in fruit fly cells, as well as F proteins--both products unlikely to arise if f were a piece of "junk DNA" left over from a long-departed retrovirus. The researchers then looked for evidence that the fruit fly regulates the f gene, switching it on and off as needed. Indeed, they found
'"/>

Source:Cornell University News Service


Page: 1 2 3

Related biology news :

1. Researchers find how protein allows insects to detect and respond to pheromones
2. Enzyme allows B cells to resist death, leading to leukemia
3. Tiny scaffolding allows stem cells to become working fat cells
4. Looks matter to female barn swallows
5. New law for resolution allows unprecedented sharpness in fluorescence microscopy
6. Researchers identify molecular anchor that allows bacterial invasion of central nervous system
7. Algal protein in worm neurons allows remote control of behavior by light
8. Why nerve cells work faster than the theory allows
9. Parachuting allows krill to eat and run
10. Tissue engineered scaffolding allows reproduction of cartilage tissue
11. Experiments provide proof of how traveling in groups protects insects

Post Your Comments:
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fr...r six months, those stents are no longer needed --...nnecessary. Previously, doctors had no choice but ... of Tel Aviv University,s Department of Biomedical...ber platform that carries drugs where they,re need...
(Date:11/24/2009)... Springer and the American College of Medical Tox...rate on the publication of the Journal of Medical...MT, beginning in March 2010. It was previously pu..., The Journal of Medical Toxicology , an intern...vancing the science and practice of medical toxico...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets ...nd until recently, there has been very little info...beneath miles of ice for millions of years. Now, a...ding LSU have been funded to the tune of $10 mill... NSF, to get to the bottom of things literally. T...
Breaking Biology News(10 mins):A coating for life 2Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
... that moonlight, having different roles at differe... being killed. The moonlighting activity of one en...ially resistant to a family of broad-spectrum anti...tember issue of the journal Microbiology. , "G...eria use to make the building blocks of cell walls...
...y recent reports documenting the therapeutic effic...odels of human disease may actually be describing ...ility of siRNA to activate an immune response, acc...ume 19, Number 9) of Human Gene Therapy , a peer-...c. The paper, which was published "instant online,...
...ncerned about the toll that mental health disorder...l have a unique opportunity to hear from world-cla...es, symptoms and progression of such illnesses as ...ia and autism, and learn about current and potenti... Healthy Minds Across America, 48 free public foru...
Other Biology News:Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3
(Date:11/24/2009)...eenmetforpatientswithadvanced-stage,orrecurrentend...e-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX...yfocusedonendocrinetherapyandoncology,todayannounc...tedcytotoxicpeptideconjugate,AEZS-108(formerlyAN-1...ncer.Inapersonalizedhealthcareapproach,thestudysel...
(Date:11/24/2009)...e-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),th...ouncedthatithassubmittedaMAAtotheEuropeanMedicines...acementtherapyindevelopment,forthetreatmentofType1...forvelaglucerasealfathathasbeensubmitted,withprevi...Basedonaglobalsupplyshortageofthecurrentlyapproved...
(Date:11/24/2009)...RNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: G...xecutiveChairman,willpresentatthe21stAnnualPiperJa...cember1,2009at10:00a.m.ET. ,, Toaccessthelivean...ttheInvestorRelationssectionofGenomicHealth,swebsi...ecttothewebsiteatleast15minutespriortothebeginning...
(Date:11/24/2009)...onnects Customers with Partners Validated to Proce...Products , Ottawa, ON (PR... provider of products for biological sample collec...ed its new global partner program. The program off...tner community and is designed to help partners sc...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ented at the AACR,meeting in San Diego efficacy an... for ovarian cancer. FAS31 is an inhibitor of fatt...xpressed in many human cancers. Numerous,studies h...ytotoxic to a,variety of human xenograft models wi...AS31 showed no observable toxicity in normal tissu...
...asdaq:,EVVV) will release its 2008 first quarter f...gular market trading hours., The company will hos...30 a.m. CT (8:30 a.m. ET). ev3 management will rev... outlook, followed by a question and answer,sessio...rested parties through a,live audio webcast at ht...
...BCI), a,biopharmaceutical company utilizing its pl...s that promote the growth of new neurons for the t... announced today that it raised an,additional $20 ... bringing,the total to $50 million. New investor, ... investors and Alexandria Real Estate Equities, In...
Other Biology Technology:FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research 2REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2
Mouse Anti-Human RDH5 Polyclonal Antibody, Unconjugated from Abnova Corporation
...Lines ,High Quality, Functionally-Validated, Ion C...or having a critical role in nerve and muscle func... CNS and the heart. Drugs that modulate ion channe...ch as neuropathic pain, cardiac arrhythmia, hypert...
The Discovery Series PDQuest Version Upgrade from Bio-Rad
Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation
Biology Products: